ERBB2 and neoplasm: Guo et al. developed a nomogram including ER status, progesterone receptor (PR) status, and tumor grade to assess HER-2 2+ status in BC patients and achieved an area under the receiver operating characteristic (ROC) curve (AUC) of 0.749 in the validation cohort [6].